TWi Biotechnology, Inc. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was TWD 1.246 million. Operating loss was TWD 46.011 million compared to TWD 59.057 million a year ago. Net loss was TWD 45.660 million compared to TWD 57.313 million a year ago. Basic loss per share was TWD 0.68 compared to TWD 0.85 a year ago.